We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Oversight Committee Unveils New Drug Pricing Investigation Reports
House Oversight Committee Unveils New Drug Pricing Investigation Reports
The House Oversight Committee has released two new staff reports from its ongoing drug pricing investigation that shed light on the tactics employed by Bristol Myers Squibb, Celgene and Teva Pharmaceuticals to raise the prices of two blockbuster drugs and turn massive profits, the same day committee Democrats grilled the company’s CEOs at its drug pricing hearing.